Detalhe da pesquisa
1.
IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells.
Gut
; 72(11): 2081-2094, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541770
2.
Non-classical monocyte homing to the gut via α4ß7 integrin mediates macrophage-dependent intestinal wound healing.
Gut
; 69(2): 252-263, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31092589
3.
Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances.
Gut
; 68(9): 1688-1700, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31127023
4.
Controlling in and out - the future of interfering with immune cell trafficking in inflammatory bowel disease.
Expert Rev Clin Immunol
; 19(2): 155-167, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427088
5.
Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease.
J Crohns Colitis
; 17(11): 1817-1832, 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208197
6.
Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4ß7 Integrin Are Decreased in COVID-19.
Front Immunol
; 12: 639329, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33959123
7.
Immunology of IL-12: An update on functional activities and implications for disease.
EXCLI J
; 19: 1563-1589, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33408595